title: Survival of athymic (nu/nu) mice after Theiler's murine encephalomyelitis virus infection by passive administration of neutralizing monoclonal antibody.
abstract: Little or no antiviral immune response is mounted in athymic nude mice infected with the Daniels strain of Theiler's murine encephalomyelitis virus. In these athymic mice, increasing levels of infectious virus could be detected in the central nervous system. Seventy-five percent (9 of 12) of the nude mice were moribund or dead by 4 weeks postinfection. In contrast, treatment of Theiler's virus-infected nude mice with a neutralizing monoclonal antibody (H7-2) against the viral protein VP-1 resulted in a dramatic reduction of infectious virus within the central nervous system. All antibody-treated nude animals survived beyond 4 weeks postinfection. Monoclonal antibody titers could be maintained by passive transfer in treated nude mice at levels comparable to those of polyclonal antibody titers found in heterozygous infected nu/+ littermates. Areas of demyelination were detected in the untreated animals as early as 7 days after infection with little or no remyelination present. In approximately one-half of the antibody-treated nude animals, no demyelinating lesions were found. However, the rest of these treated mice were found to have areas of both demyelination and remyelination. Thus, anti-Theiler's murine encephalomyelitis virus antibody against VP-1 can play a dramatic role in the survival of mice, clearance of virus, limiting viral spread, and altering the pattern of disease in the absence of a functional T-cell response.
authors.affiliation: Department of Pathology, School of Medicine, University of California, San Diego, La Jolla 93093.
authors.forename: R S
authors.initials: RS
authors.lastname: Fujinami
authors.forename: A
authors.initials: A
authors.lastname: Rosenthal
authors.forename: P W
authors.initials: PW
authors.lastname: Lampert
authors.forename: A
authors.initials: A
authors.lastname: Zurbriggen
authors.forename: M
authors.initials: M
authors.lastname: Yamada
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000914:Antibodies, Viral / Q000276:immunology; D001921:Brain / Q000382:microbiology; D004679:Encephalomyelitis / Q000276:immunology / Q000382:microbiology / Q000473:pathology / Q000517:prevention & control*; D004770:Enterovirus / Q000276:immunology*; D004769:Enterovirus Infections / Q000276:immunology / Q000382:microbiology / Q000473:pathology / Q000517:prevention & control*; D007116:Immunization, Passive; D004680:Maus Elberfeld virus / Q000276:immunology* / Q000472:pathogenicity; D051379:Mice; D008819:Mice, Nude; D009500:Neutralization Tests; D014764:Viral Proteins / Q000276:immunology; D014779:Virus Replication
chemical_list: D000911:Antibodies, Monoclonal; D000914:Antibodies, Viral; D014764:Viral Proteins